eNOS polymorphism associated with metabolic syndrome in children and adolescents (2013)
- Autores:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1007/s11010-012-1456-y
- Assuntos: POLIMORFISMO; CRIANÇAS; ADOLESCENTES
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Molecular and Cellular Biochemistry
- ISSN: 0300-8177
- Volume/Número/Paginação/Ano: v. 372, n. 1-2, p. 155-160, 2013
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MIRANDA, Josiane A. et al. eNOS polymorphism associated with metabolic syndrome in children and adolescents. Molecular and Cellular Biochemistry, v. 372, n. 1-2, p. 155-160, 2013Tradução . . Disponível em: https://doi.org/10.1007/s11010-012-1456-y. Acesso em: 24 abr. 2024. -
APA
Miranda, J. A., Belo, V. A., Souza-Costa, D. C., Lanna, C. M. M., & Tanus-Santos, J. E. (2013). eNOS polymorphism associated with metabolic syndrome in children and adolescents. Molecular and Cellular Biochemistry, 372( 1-2), 155-160. doi:10.1007/s11010-012-1456-y -
NLM
Miranda JA, Belo VA, Souza-Costa DC, Lanna CMM, Tanus-Santos JE. eNOS polymorphism associated with metabolic syndrome in children and adolescents [Internet]. Molecular and Cellular Biochemistry. 2013 ; 372( 1-2): 155-160.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1007/s11010-012-1456-y -
Vancouver
Miranda JA, Belo VA, Souza-Costa DC, Lanna CMM, Tanus-Santos JE. eNOS polymorphism associated with metabolic syndrome in children and adolescents [Internet]. Molecular and Cellular Biochemistry. 2013 ; 372( 1-2): 155-160.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1007/s11010-012-1456-y - Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6
- Sequence diversity and functional charactterization of the 5´-regulatory region of human cyp2c19
- Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction
- Nitrate decreases xanthine oxidoreductase-mediated nitrite reductase activity and attenuates vascular and blood pressure responses to nitrite
- eNOS gene polymorphirms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity [Carta]
- Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes
- Hemodynamic effects of bupropion in anesthetized dogs
- Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism
- Severity dependent increases in circulating cardiac troponin I and MMP-9 concentrations after experimental acute pulmonary thromboembolism
- Functional polymorphism located in MMP-9 gene promoter is strongly associated with obesity
Informações sobre o DOI: 10.1007/s11010-012-1456-y (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
